ABCG2 and glioblastoma: Strategies to design nanocarriers and to inhibit ABC transporters have greatly advanced in recent years, particularly through research on glioblastoma therapies.1,32 It is conceivable that transport of these drug vehicles could benefit from utilizing caveolar transcytosis, which can be achieved by co-application of inhalation anesthetics.